An international study to evaluate therapeutic options for #PIMS-TS / #MIS-C to help identify which patients to treat and which treatments work.

Joined January 2021
Pleased to announce that BATS is about to start our 2nd round of analysis of patients with #MISC. Paediatricians around the world have recruited an incredible 2080 patients with PIMS-TS/MIS-C, from over 35 countries. Watch this space! #IDresearch #dataanalysis
1
20
7
37
We are excited to present our first findings from the BATS study at #ESPID2021 looking at treatment effectiveness in #MIS_C. Can't wait to see you there! @ESPIDsociety
1
19
1
33
The incredible body of data being collected as part of this study will help us to really understand which treatments work in #PIMS_TS/#MIS_C Huge thanks to those that have helped recruit over 430 patients! To find out more and enrol your patients, visit bestavailabletreatmentstudy.…
3
13
27
Patients have been recruited from 157 sites in the highlighted countries in this truly international effort to identify the best treatments for #PIMS_TS / #MIS_C. Find out more and start enrolling patients by visiting: bestavailabletreatmentstudy.…
1
8
2
11
Clinicians around the world have recruited 399 patients with PIMS-TS/MIS-C into the Best Available Treatment Study to help understand the best treatments for this rare but important new disease in children To find out more and enrol patients, check out bestavailabletreatmentstudy.…
1
12
1
13